Cargando…
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer
The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and over treatment of prostate cancer has g...
Autores principales: | Sahoo, Debashis, Wei, Wei, Auman, Heidi, Hurtado-Coll, Antonio, Carroll, Peter R., Fazli, Ladan, Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Simko, Jeff, Thompson, Ian M., Leach, Robin J., Troyer, Dean A., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Brooks, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814231/ https://www.ncbi.nlm.nih.gov/pubmed/29464091 http://dx.doi.org/10.18632/oncotarget.23973 |
Ejemplares similares
-
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients
por: Brooks, James D., et al.
Publicado: (2015) -
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study
por: Eminaga, Okyaz, et al.
Publicado: (2016) -
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
por: Troyer, Dean A, et al.
Publicado: (2015) -
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for “large” cribriform prostatic adenocarcinoma
por: Chan, Emily, et al.
Publicado: (2022) -
Analytic Validation of a Clinical-Grade PTEN Immunohistochemistry Assay in Prostate Cancer by Comparison to PTEN FISH
por: Lotan, Tamara L., et al.
Publicado: (2016)